Very interesting companies, I have some Qbiotics but would like to own some of the other one day. They aren't currently listed but they're making murmurs like they will list after human trials (which they are obviously hoping will be a success).
Qbiotics has 3 drugs (pretty sure)..
EBC-46 - This is the one the article above refers to and they've had great success in animals to date. This is applies topically as a gel or injected into tumours.
EBC-23 - This one is a variation of EBC-46 and they're hoping this can attack tumours anywhere in the body (this is from memory, I'm not positive on the nitty gritty here)
WH-1 - This is a wound healing drug which apparently is a big thing. In it's infancy but showing promise nonetheless.
The most attractive thing about Qbiotics which sets it apart from other bio investments, apart from having an extremely promising anti-cancer drug, is that it already works in animals which is a huge market in itself. This also gives certain efficiencies in R&D where they can essentially spend half the money by studying both human and animal in parallel.
Victoria Gordon is great too, she is not just a nutty scientist. She has a vested interest to see this work and to date I really can't fault her. She'd put a lot of MD/CEO's to shame on the ASX.
Also for anyone interested and scientifically minded, check out this article below.. Would be really interested to hear a nutty professors take on the link at the bottom of the article. It is a research article of the experiment..
